Science Intelligence and InfoPros

Little things about Scientitic Watch and Information Professionnals

SM & Pharmas: the industry awaits FDA guidance

with one comment


  Consumers increasingly are tapping the Internet and social media sites for health-related information. A recent survey conducted by the Pew Internet Project and the California HealthCare Foundation, which publishes iHealthBeat, found that 80% of Internet users look up medical-related information online. (…)

While online, consumers are likely to view promotions for health care products, but there currently are no federally imposed rules of the road governing pharmaceutical marketing activities (…)

FDA says the earliest it will take action is the first quarter of 2011

FDA is studying guidelines on several fronts, including:

  • How companies can respond to unsolicited consumer requests;
  • How companies can comply with regulations in the face of space constraints on sites like Facebook and Twitter;
  • How companies can fulfill post-marketing submission requirements;
  • What type of communications manufacturers or distributors are accountable for;
  • Using links on the Internet; and
  • How to correct misinformation.


(…) the industry has to find a harmony between offering information to consumers and health care professionals and making sure that that information is not misleading. In the “best interest of public health,” FDA is urgingthe regulated industry to ensure their product promotion is accurate, balanced and non-misleading regardless of the medium.

The opportunities to disseminate and share information across a global, online enterprise are almost incalculable, as is the amount of data at the fingertips of anyone with an Internet connection or smart phone. It remains to be seen how product marketing will co-exist alongside FDA scrutiny and just how detailed FDA guidelines will be.

 Pogachar, Mickael. Questions Linger on Social Media Regulations for Pharma. iHealthBeat, Tuesday, March 01, 2011


Written by hbasset

March 3, 2011 at 8:25 pm

One Response

Subscribe to comments with RSS.

  1. […] SM & Pharmas: a attention awaits FDA superintendence « Science … […]

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: